This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nuttall, J. P.
Right arrow Articles by Mitchnick, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nuttall, J. P.
Right arrow Articles by Mitchnick, M. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2008, p. 909-914, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.00330-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Concentrations of Dapivirine in the Rhesus Macaque and Rabbit following Once Daily Intravaginal Administration of a Gel Formulation of [14C]Dapivirine for 7 Days{triangledown}

Jeremy P. Nuttall,1* Daryl C. Thake,2 Mark G. Lewis,3 John W. Ferkany,4 Joseph W. Romano,1 and Mark A. Mitchnick5

International Partnership for Microbicides, Silver Spring, Maryland,1 Seventh Wave Pathology and Biotechnical Solutions, LLC, Chesterfield, Missouri,2 BioQual, Inc., Rockville, Maryland,3 PharmaDirections, Cary, North Carolina,4 Particle Sciences, Inc., Bethlehem, Pennsylvania5

Received 9 March 2007/ Returned for modification 27 April 2007/ Accepted 5 December 2007

Dapivirine is a nonnucleoside reverse transcriptase inhibitor being developed as a topical microbicide for the prevention of human immunodeficiency virus infection. The distribution of radioactivity and drug in plasma and in vaginal, cervical, and draining lymph node tissues was investigated after daily application of a vaginal gel formulation of [14C]dapivirine to rhesus macaques. This was preceded by a preliminary study with rabbits. Following the intravaginal administration of [14C]dapivirine (~0.1 mg/ml [15 µCi/ml]) to rabbits (0.5 ml/day) and macaques (1 ml/day) for 7 days, the dapivirine levels associated with vaginal and cervical tissue samples 1 h after the final dose were high (quantities of µg/g of tissue) and remained detectable at 24 h (mean, ≥2.5 ng/g in rabbits) and 48 h (mean, >80 ng/g in macaques). Radioactivity levels were low in the plasma and very low or unquantifiable in the draining lymph nodes of the macaques. Microautoradiography identified drug-related material (DRM) on the surfaces of the vaginal and cervical tissues of the rabbits and macaques. Although DRM was primarily associated with the outermost layer of shedding cells in rabbits, two animals showed some evidence of small quantities in the mucosal epithelium of the cervix. In macaques, DRM was seen within the keratinized layer of the vaginal epithelium and and was found to extend into the superficial cellular layers, and in at least one animal it appeared to be present in the deepest (germinal) layer of the epithelium and in submucosal tissues. The persistence of biologically significant concentrations of dapivirine in vaginal and cervical tissues for >24 h supports the development of dapivirine as a microbicide for once daily application.

* Corresponding author. Mailing address: International Partnership for Microbicides, 8401 Colesville Road, Suite 200, Silver Spring, MD 20910. Phone: (301) 608-2221. Fax: (301) 608-2241. E-mail: jnuttall{at}ipm-microbicides.org

{triangledown} Published ahead of print on 17 December 2007.

Antimicrobial Agents and Chemotherapy, March 2008, p. 909-914, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.00330-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Fletcher, P., Harman, S., Azijn, H., Armanasco, N., Manlow, P., Perumal, D., de Bethune, M.-P., Nuttall, J., Romano, J., Shattock, R. (2009). Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor. Antimicrob. Agents Chemother. 53: 487-495 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»